1,25-Dihydroxycholecalciferol: Endocrinology meets the immune system

Proceedings of the Nutrition Society

Volumn 61, Issue 3, 2002, Pages 375-380

  Van Etten, Evelyne ^a   Decallonne, Brigitte ^a   Mathieu, Chantal ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

1,25 Dihydroxycholecalciferol; NOD mice; Type 1 diabetes

Indexed keywords

CALCITRIOL; CALCITRIOL DERIVATIVE; COLECALCIFEROL; IMMUNOMODULATING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; CELL PROTECTION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG MECHANISM; ENDOCRINOLOGY; HELPER CELL; IMMUNE SYSTEM; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PANCREAS ISLET BETA CELL; PRIMARY PREVENTION; PROTEIN EXPRESSION; SECONDARY PREVENTION; T LYMPHOCYTE;

ANIMALS; CALCITRIOL; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; ENDOCRINE SYSTEM; HUMANS; IMMUNE SYSTEM; LYMPHOCYTES; MICE; MICE, INBRED NOD;

ANIMALIA;

EID: 0036690834     PISSN: 00296651     EISSN: None     Source Type: Journal    
DOI: 10.1079/PNS2002170     Document Type: Conference Paper

References (30)

1. Non-hypercalcemic pharmacological aspects of vitamin D analogs
2. 3 in vitro and in vivo
3. 3
4. 3 in combination with cyclosporin A
5. 3 restores sensitivity to cyclophosphamide-induced apoptosis in NOD mice and protects against diabetes
6. 3 restores defect
7. 3 analogue and cyclosporin A
8. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages
9. Vitamin D supplement in early childhood and risk for type 1 (insulin-dependent) diabetes mellitus
10. 3
11. A combination of KH1060, a vitamin D3 analogue and cyclosporin prevents early graft failure and prolongs graft survival of xenogeneic islets in non obese diabetic mice
12. Leflunomide and its analogue X920715 synergize with cyclosporin A in preventing early graft failure and delaying graft rejection of xenogeneic islets in non-obese-diabetic mice
13. Early graft failure of xenogeneic islets in NOD mice is accompanied by high levels of interleukin-1 and low levels of transforming growth factor-β mRNA in the grafts
14. 3 reduces MHC antigen expression on pancreatic beta-cells in vitro
15. Short-term exclusive breast-feeding predisposes young children with increased genetic risk of Type 1 diabetes to progressive beta-cell autoimmunity
16. Current limitations of islet transplantation
17. 3 analogs as immunomodulatory agents
18. 3] and its analogues as dose reducing agents for cyclosporin and FK506 in vitro and in vivo
19. 3 in combination with CyA
20. 3 prevents insulitis in NOD mice
21. 3, KH1060
22. 3
23. Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages
24. 1,25-Dihydroxyvitamin D3 induces an autoantigen specific Th1/Th2 immune shift in nonobese diabetic mice immunized with GAD65 (p524-543)
25. 3 inhibits differentiation, maturation, activation and survival of dendritic cells leading to impaired alloreactive T cell activation
26. 3 on cytokine-treated human pancreatic islets
27. Analogs of 1,25-dihydroxyvitamin D3 as dose reducing agents for classical immunosuppressants
28. 3
29. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system
30. Recent developments in the use of vitamin D analogues